| Dr Giovanni Disandro Jr, MD | |
|
885 Kempsville Rd Ste 101, Norfolk, VA 23502-3800 | |
| (757) 461-1444 | |
| (757) 461-8238 |
| Full Name | Dr Giovanni Disandro Jr |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 15 Years |
| Location | 885 Kempsville Rd Ste 101, Norfolk, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497997712 | NPI | - | NPPES |
| 501106 | Other | VA | ANTHEM BC/BS |
| PAR | Other | VA | AETNA |
| 1497997712 | Medicaid | NC | |
| PAR | Other | VA | USA MANAGED CARE |
| 1497997712 | Other | VA | VIRGINIA PREMIER HEALTH PLAN |
| 1497997712 | Other | VA | COVENTRY NETWORK |
| PAR | Other | VA | CIGNA |
| PAR | Other | VA | MULTIPLAN |
| 10116316 | Other | VA | OPTIMA HEALTH |
| 1497997712 | Medicaid | VA | |
| PAR | Other | VA | VIRGINIA HEALTH NETWORK |
| -019 | Other | VA | TRICARE/CHAMPUS |
| 1497997712 | Other | VA | UNITED HEALTHCARE |
| PAR | Other | VA | CORVEL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207WX0200X | Ophthalmology - Ophthalmic Plastic And Reconstructive Surgery | 0101254154 (Virginia) | Secondary |
| 207W00000X | Ophthalmology | 0101254154 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Norfolk General Hospital | Norfolk, VA | Hospital |
| Sentara Leigh Hospital | Norfolk, VA | Hospital |
| Sentara Virginia Beach General Hospital | Virginia beach, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Evms Academic Physicians And Surgeons Health Services Foundation | 5698675510 | 187 |
News Archive
A newly-discovered hereditary mutation is responsible for an increased production of erythropoietin (EPO) in the blood.
Long-term exposure to particulate matter is associated with an increased risk for heart attack. Moreover, this association can already be observed in levels of particulate exposure below the current specified European limit values.
Parents of children who suffer with asthma are making many efforts to clear their homes of substances that could trigger their child's symptoms, but the steps they take aren't always the ones that could do the most good, a new University of Michigan study finds. And many don't take other steps that are known to help.
A new study on syphilis has revealed the horrifying truth that more men than ever are contracting the sexually transmitted infection (STI) syphilis in Europe. The most heavily infected group comprises men having sex with men (MSM). At present, syphilis affects more people than HIV in the European Union.
Juventas Therapeutics, a clinical-stage regenerative medicine company developing novel therapies for cardiovascular disease, announces that the U.S. Food and Drug Administration (FDA) authorized commencement of a Phase II clinical trial evaluating the efficacy and safety of its lead product, JVS-100, for the treatment of critical limb ischemia (CLI).
› Verified 6 days ago
| Entity Name | Evms Academic Physicians And Surgeons Health Services Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003887118 PECOS PAC ID: 5698675510 Enrollment ID: O20040304001377 |
News Archive
A newly-discovered hereditary mutation is responsible for an increased production of erythropoietin (EPO) in the blood.
Long-term exposure to particulate matter is associated with an increased risk for heart attack. Moreover, this association can already be observed in levels of particulate exposure below the current specified European limit values.
Parents of children who suffer with asthma are making many efforts to clear their homes of substances that could trigger their child's symptoms, but the steps they take aren't always the ones that could do the most good, a new University of Michigan study finds. And many don't take other steps that are known to help.
A new study on syphilis has revealed the horrifying truth that more men than ever are contracting the sexually transmitted infection (STI) syphilis in Europe. The most heavily infected group comprises men having sex with men (MSM). At present, syphilis affects more people than HIV in the European Union.
Juventas Therapeutics, a clinical-stage regenerative medicine company developing novel therapies for cardiovascular disease, announces that the U.S. Food and Drug Administration (FDA) authorized commencement of a Phase II clinical trial evaluating the efficacy and safety of its lead product, JVS-100, for the treatment of critical limb ischemia (CLI).
› Verified 6 days ago
| Entity Name | Virginia Ophthalmology Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275588477 PECOS PAC ID: 1658344908 Enrollment ID: O20040816001002 |
News Archive
A newly-discovered hereditary mutation is responsible for an increased production of erythropoietin (EPO) in the blood.
Long-term exposure to particulate matter is associated with an increased risk for heart attack. Moreover, this association can already be observed in levels of particulate exposure below the current specified European limit values.
Parents of children who suffer with asthma are making many efforts to clear their homes of substances that could trigger their child's symptoms, but the steps they take aren't always the ones that could do the most good, a new University of Michigan study finds. And many don't take other steps that are known to help.
A new study on syphilis has revealed the horrifying truth that more men than ever are contracting the sexually transmitted infection (STI) syphilis in Europe. The most heavily infected group comprises men having sex with men (MSM). At present, syphilis affects more people than HIV in the European Union.
Juventas Therapeutics, a clinical-stage regenerative medicine company developing novel therapies for cardiovascular disease, announces that the U.S. Food and Drug Administration (FDA) authorized commencement of a Phase II clinical trial evaluating the efficacy and safety of its lead product, JVS-100, for the treatment of critical limb ischemia (CLI).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Giovanni Disandro Jr, MD 885 Kempsville Road, Suite 101, Norfolk, VA 23502-3800 Ph: (757) 461-1444 | Dr Giovanni Disandro Jr, MD 885 Kempsville Rd Ste 101, Norfolk, VA 23502-3800 Ph: (757) 461-1444 |
News Archive
A newly-discovered hereditary mutation is responsible for an increased production of erythropoietin (EPO) in the blood.
Long-term exposure to particulate matter is associated with an increased risk for heart attack. Moreover, this association can already be observed in levels of particulate exposure below the current specified European limit values.
Parents of children who suffer with asthma are making many efforts to clear their homes of substances that could trigger their child's symptoms, but the steps they take aren't always the ones that could do the most good, a new University of Michigan study finds. And many don't take other steps that are known to help.
A new study on syphilis has revealed the horrifying truth that more men than ever are contracting the sexually transmitted infection (STI) syphilis in Europe. The most heavily infected group comprises men having sex with men (MSM). At present, syphilis affects more people than HIV in the European Union.
Juventas Therapeutics, a clinical-stage regenerative medicine company developing novel therapies for cardiovascular disease, announces that the U.S. Food and Drug Administration (FDA) authorized commencement of a Phase II clinical trial evaluating the efficacy and safety of its lead product, JVS-100, for the treatment of critical limb ischemia (CLI).
› Verified 6 days ago
Vincent James Verdi, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3921 Granby St, Suite A, Norfolk, VA 23504 Phone: 757-583-5826 Fax: 757-588-2712 | |
David M Salib, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 241 Corporate Blvd, Norfolk, VA 23502 Phone: 757-622-2200 Fax: 757-622-4866 | |
Dr. Andrew R Miller, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 241 Corporate Blvd, Norfolk, VA 23502 Phone: 757-663-5348 | |
Dr. Thomas John Joly, MD PHD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 241 Corporate Blvd, Norfolk, VA 23502 Phone: 757-622-2200 | |
Dr. Kapil Gopal Kapoor, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6160 Kempsville Cir Ste 120b, Norfolk, VA 23502 Phone: 757-481-4400 Fax: 757-481-1285 | |
Esther I-ping Chang, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 241 Corporate Blvd, Suite 210, Norfolk, VA 23502 Phone: 757-622-2200 Fax: 757-965-9493 | |
Alaa Al-dabbagh, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 6160 Kempsville Cir Ste 120b, Norfolk, VA 23502 Phone: 757-481-4400 Fax: 757-481-1285 |